Bills › 90th General Assembly

HF 423Signed by Governor · April 28, 2023

Relating to contract pharmacies and covered entities that participate in the 340B drug program

Sponsored by the House Health and Human Services Committee

Topics:Health careInsurancePrescription drug pricesMedicaid

Same legislation: SSB 1098, HSB 137, SF 419

Where it is now

  1. Done: IntroducedFebruary 7, 2023
  2. Done: SubcommitteeFebruary 7, 2023
  3. Done: House committeeFebruary 21, 2023
  4. Done: Passes the HouseMarch 7, 202398–0
  5. Done: Senate committeeMarch 30, 2023
  6. Done: Passes the SenateApril 20, 202349–1
  7. Done: To the GovernorApril 28, 2023
  8. Done: Signed into lawApril 28, 2023

Signed into law What’s a funnel?

What’s in it

AI summary Insurance companies and pharmacy managers cannot treat pharmacies or healthcare providers differently just because they participate in the 340B drug discount program. These companies are prohibited from paying these providers less for drugs or fees than they pay other similar pharmacies. The law also prevents them from placing unfair restrictions on how patients receive their medicine from these specific providers.1

Read the official explanation

This bill relates to contract pharmacies and covered entities that participate in the 340B program. The bill defines “340B program”, “contract pharmacy”, and “covered entity”. Group health plans (plans), health carriers that offer group or individual health insurance coverage (carriers), third-party administrators (administrators), and pharmacy benefits managers (PBM) are prohibited from discriminating against a covered entity or a contract pharmacy by reimbursing the covered entity or the contract pharmacy for a prescription drug or a dispensing fee in an amount less than the plan, carrier, administrator, or PBM reimburses a similarly situated entity or pharmacy that is not a covered entity or a contract pharmacy. “Similarly situated entity or pharmacy” is defined in the bill. Plans, carriers, administrators, and PBMs shall not, on the basis that an entity is a covered entity or that a pharmacy is a contract pharmacy, or that a covered entity or contract pharmacy participates in the 340B program, impose certain contractual terms and conditions, as described in the bill, on the covered entity or contract pharmacy that differ from those imposed on a similarly situated entity or pharmacy that is not a covered entity or a contract pharmacy. Plans, carriers, administrators, and PBMs are also prohibited from, on the basis that an entity is a covered entity or that a pharmacy is a contract pharmacy, or that a covered entity or a contract pharmacy participates in the 340B program, placing restrictions or imposing requirements on individuals that choose to obtain a covered outpatient drug from a covered entity or a contract pharmacy, whether in person, via courier or the United States post office, or any other form of delivery; refusing to contract with a covered entity or a contract pharmacy based on any criteria that is not applied equally to a contract with a similarly situated entity or pharmacy that does not participate in the 340B program; or imposing any restriction or condition on a covered entity that interferes with the covered entity’s ability to maximize the value of the discounts obtained by the covered entity through the covered entity’s participation in the 340B program. “Group health plan” and “third-party administrator” are defined in the bill. The commissioner of insurance (commissioner) may take any enforcement action under the commissioner’s authority to enforce compliance with the bill.7 upon a finding that a plan, a carrier, an administrator, or a PBM violated any provision of the bill.4(3). The commissioner may adopt rules as necessary to implement the bill. If any provision of the bill is inconsistent or in conflict with applicable state or federal law or rule, or the state Medicaid plan, the state or federal law or rule, or the state Medicaid plan, shall prevail to the extent necessary to eliminate the inconsistency or conflict. The bill applies to covered entities, contract pharmacies, plans, carriers, administrators, and PBM, but shall not apply to their operations under a contract with the state Medicaid agency or a Medicaid managed care organization, regardless of whether the covered entity or contract pharmacy is eligible to retain the 340B discounts generated by the covered entities and contract pharmacies. “Medicaid managed care organization” is defined in the bill.

Full bill text · What changed before it passed2

House subcommittee

Named February 7, 2023 (as HSB 137). On February 8, 2023 it recommended passage. Vote Total: 3-0.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Fiscal note

Can’t be estimated Compare with other bills

AI summary This bill prohibits insurance plans, carriers, and pharmacy benefit managers from discriminating against pharmacies or entities participating in the 340B drug program. While the Iowa Insurance Division will not need to hire new staff to enforce these rules, the bill has the potential to generate increased costs to the State of Iowa and the State of Iowa health plan. The exact fiscal impact of these changes is unknown.3

Read the fiscal note

Description

Senate File 419 relates to contract pharmacies and covered entities that participate in the 340B drug program and does the following:

  • Defines terms.
  • Prohibits plans, carriers, third-party administrators (TPAs), and pharmacy benefits managers (PBMs) from providing discriminatory reimbursement amounts for prescription drugs or dispensing fees on the basis of a covered entity’s or a contract pharmacy’s status as a covered entity or contract pharmacy.
  • Prohibits discrimination on the basis of participation in a 340B drug program, in addition to the status as a covered entity or a contract pharmacy, for the following:
  • Imposing contractual terms and conditions, as specified in the Bill.
  • Placing restrictions or imposing requirements on an individual that chooses to obtain a covered outpatient drug from a covered entity or a contract pharmacy.
  • Refusing to contract with a covered entity or a contract pharmacy based on any criteria that is not applied equally.
  • Imposing restrictions that interfere with the ability to maximize discounts through participation in a 340B drug program.
  • Permits the Commissioner of Insurance to take enforcement action under the Commissioner’s authority to enforce compliance. After notice and hearing, the Commissioner may issue any order or impose any penalty pursuant to Iowa Code section 507B.7 upon finding a violation of this Bill.
  • Establishes that a violation of this Bill violates Iowa Code section 507B.4(3) pertaining to unfair or deceptive acts or practices in the business of insurance.
  • Permits the Commissioner to adopt rules implementing the provisions of this Bill.
  • Clarifies that if any provisions of this Bill are in conflict with applicable State or federal law, that the State or federal law will prevail to the extent necessary to eliminate the conflict.
  • Establishes applicability.

Background

The 340B drug program refers to the program created pursuant to the Veterans Health Care Act of 1992, codified as §340B of the federal Public Health Services Act.

Senate File 419 is estimated to impact approximately 25.8% of the Iowa population (822,000). This includes individual coverage, fully insured small and large employer groups, self-insured public employees, and the State of Iowa Plan.

Of the individuals not covered by the mandate, approximately 45.2% are covered by government-sponsored health insurance, 23.0% are covered by employer coverage that is governed by the federal Employee Retirement Income Security Act of 1974 (ERISA), and the remaining 6.0% are uninsured.

Assumption

The Iowa Insurance Division will not need to hire additional full-time equivalent (FTE) positions to enforce the provisions of this Bill.

Fiscal Impact

Senate File 419 has the potential to generate increased costs to the State of Iowa and the State of Iowa health plan, but the fiscal impact is unknown.

Sources

  • Board of Regents
  • Iowa Insurance Division, Department of Commerce
  • Legislative Services Agency
  • Wellmark

Reading a fiscal note4

Iowa Code it changes

Creates§510D.1§510D.2§510D.3§510D.4§510D.5§510D.6

Amends§507B.4

How the Code works5

Lobbying

19 for · 1 against · 16 undecided · Who →

Family tree